Researchers have found a delivery method for gene therapy that reaches all the voluntary muscles of a mouse – including heart, diaphragm and limbs – and reverses the process of muscle-wasting found in muscular dystrophy. Delivered by simple injection, the virus goes only for muscle cells and does not trigger the immune system. Results will appear in the August issue of Nature Medicine.